Moreover, NAB positive patients, but not those with auto‐Abs without anti‐IFN neutralizing activity, have raised levels of CRP, and significant alterations in total WBC, neutrophils, and platelets, suggesting that NAB status and the resulting impairment of IFN response are important pathogenic factors for COVID‐19 severity. The gene discussed is IFNA1; the disease is COVID-19.